Tuesday, September 17, 2002

Study results offer new hope for people with manic depression
Shire Health International press release - "Results from a clinical trial presented for the first time today at Europe's largest Conference on Bipolar Disorder, reveal that Seroquel (quetiapine), a medication currently used to treat patients with schizophrenia, could offer a more effective therapy for the millions of people worldwide suffering from bipolar disorder."  
  

Affluent youth prone to high distress, substance abuse
Center for the Advancement of Health press release on a study by researchers at Teachers College, Columbia University which found that "affluent, suburban middle-school students may face certain pressures that make them susceptible to depression and more likely to smoke or use drugs and alcohol."  
  

Using naltrexone to treat alcoholics with a 'Mediterranean drinking pattern'
Press release on a study in the September issue of Alcoholism: Clinical & Experimental Research that is "among the first to examine the effectiveness and safety of naltrexone for the treatment of alcoholism among Spanish patients with a Mediterranean drinking pattern."